Structured Clinical

Related by string. * structuring . Structuring . structurer . STRUCTURED . structured : High Grade Structured . Structured Finance CDOs . structured finance . Structured Finance . structured cabling systems / clinicals . CLINICAL . Clinicals . clinical : Phase III clinical trials . placebo controlled clinical trials . Phase III clinical . Phase 2b clinical . Clinical Excellence NICE * *

Related by context. All words. (Click for frequent words.) 78 DSM IV Axis 74 DSM IV SCID 61 semistructured interview 61 DSM IV disorders 61 DSM IV diagnosis 61 Female Sexual Function 61 Diagnostic Interview 61 convergent validity 60 somatoform disorders 60 psychometric properties 60 DSM IV criteria 60 syndromal 59 DSM IV diagnoses 59 interrater reliability 59 hypochondriasis 58 subscale scores 58 Mental Disorders DSM IV 58 CORE OM 58 STEP BD 58 DSM IV 57 premorbid 57 avoidant personality disorder 57 WAIS III 57 neurocognitive function 57 somatization disorder 57 retest reliability 57 multiple linear regression 57 nonpsychotic 57 euthymic patients 57 Montgomery Åsberg Depression 57 Suicidal ideation 56 Child Behavior Checklist 56 binary logistic regression 56 Neuropsychiatric Inventory NPI 56 meta regression 56 HRQL 56 semistructured interviews 56 euthymic 56 affective disorders 56 schizophrenia schizoaffective disorder 56 Mental Disorders Fourth 56 somatization 56 retrospective cohort 56 suicide attempters 56 covariate 56 logistic regression analysis 56 psychodynamic psychotherapy 55 Sociodemographic 55 MMSE score 55 untreated psychosis 55 QoL 55 subscales 55 logistic regression 55 alexithymia 55 DSM IV TR 55 HRQOL 55 neuropsychological assessment 55 randomized controlled trials RCTs 55 Univariate 55 psychiatric comorbidities 55 multivariate logistic regression 55 EQ 5D 55 Depressive symptoms 55 overnight polysomnography 55 HAM D# 55 depressive symptomatology 55 multiple logistic regression 55 posttreatment 55 cognitive affective 55 Likert scale 55 comorbid anxiety 55 prospective longitudinal 55 Bonferroni correction 55 semistructured 55 bivariate analyzes 54 sociodemographic characteristics 54 Incontinence Impact Questionnaire 54 logistic regression model 54 variance ANOVA 54 Brief Psychiatric 54 bulimia nervosa 54 QIDS SR 54 interobserver 54 somatic symptoms 54 psychophysiological 54 conditional logistic regression 54 DSM IV diagnostic 54 psychoeducation 54 comorbidity 54 Comorbidity 54 logistic regression analyzes 54 Multiple logistic regression 54 Meta analyzes 54 exploratory endpoints 54 familial aggregation 54 EORTC QLQ C# 54 clinico pathological 54 MDQ 54 Kruskal Wallis test 54 Rating Scale BPRS 54 psychiatric diagnoses 54 chronicity 54 psychopathological symptoms 54 symptom severity 54 Poisson regression 54 Index FSFI 54 schizophreniform disorder 54 psychopathology 53 probands 53 Pearson correlation coefficient 53 symptom checklist 53 univariate analyzes 53 subscores 53 Edinburgh Postnatal Depression 53 sociodemographic variables 53 BPRS 53 multivariate analyzes 53 differential gene expression 53 comorbid psychiatric 53 predictive validity 53 Personality Questionnaire 53 T2DM 53 HRQoL 53 Index CDAI 53 Neuroticism 53 p = .# [002] 53 semiquantitative 53 Descriptive statistics 53 posttest 53 PANSS 53 Pearson correlation coefficients 53 psychiatric morbidity 53 ANCOVA 53 diabetes mellitus DM 53 Logistic regression 53 preoperative PSA 52 polysomnogram 52 covariates 52 intraclass correlation coefficients 52 neurocognitive impairment 52 syndromic 52 GH deficiency 52 nonpharmacologic 52 IIEF 52 cytoreductive nephrectomy 52 generalized estimating 52 HRCT 52 comorbid 52 chi squared 52 comorbid conditions 52 symptomatology 52 primary aldosteronism 52 unipolar depression 52 neuroleptic 52 comorbid disorders 52 schizotypal 52 advanced neoplasia 52 multivariable logistic regression 52 postintervention 52 univariate 52 interrater 52 HAMD 52 subsyndromal 52 interpersonal psychotherapy 52 electrophysiologic 52 psychosocial functioning 52 Social Phobia 52 subthreshold 52 #q# deletion syndrome 52 psychiatric outpatients 52 Wechsler Adult 52 tonsillar hypertrophy 52 sociodemographic 52 generalized anxiety disorder 52 point Likert scale 52 Geriatric Depression 52 logistic regression models 52 antiepileptics 52 Primary endpoints 52 spirometric 52 Multivariate analysis 52 comorbid depression 52 NHAMCS 52 psychodynamic therapy 52 Generalized Anxiety Disorder 52 dissociative disorders 52 Posttraumatic Stress Disorder PTSD 52 Epworth Sleepiness Scale 52 affective psychoses 52 Distress Scale 52 Psychosomatic Research 52 APOE genotype 52 hypomanic symptoms 52 Symptom Checklist 51 comorbid psychiatric disorders 51 AGHD 51 logistic regressions 51 erection hardness 51 covariance 51 internalizing disorders 51 Secondary efficacy endpoints 51 psychiatric inpatients 51 empirically validated 51 Longitudinal studies 51 transcranial Doppler ultrasound 51 affective psychosis 51 MMSE 51 chronic prostatitis chronic 51 Major Depressive Disorder 51 Arch Surg 51 Diagnostic Criteria 51 Multivariate logistic regression 51 Global Impression CGI 51 depressive symptom 51 pre operatively 51 Antisocial Personality Disorder 51 prostate carcinoma 51 diagnosing ADHD 51 overactive bladder symptoms 51 NESARC 51 psychometric 51 hematopoietic cancers 51 HER2 overexpression 51 bacterial prostatitis 51 Comorbid 51 tryptophan depletion 51 microalbumin 51 comorbid diagnoses 51 Neuropsychological 51 Negative Syndrome 51 Relieve Depression 51 Haptoglobin 51 preintervention 51 bivariate 51 transient elastography 51 Replication NCS R 51 somatoform disorder 51 prognostic indicators 51 Hypoactive Sexual Desire Disorder 51 actigraphy 51 Cognitive behavioral 51 multivariate Cox 51 cytologic 51 prucalopride 51 prospectively enrolled 51 chi ^ sup 50 F FDG PET 50 immunostaining 50 Neurocognitive 50 PHQ 9 50 PNES 50 autonomic dysfunction 50 poststroke 50 Histologic 50 subclinical hypothyroidism 50 neuropsychological tests 50 EEG recordings 50 anxiety disorders 50 genotypic 50 Psychodynamic 50 bivariate analysis 50 odds ratios ORs 50 Depressive Symptoms 50 State Trait Anxiety 50 sociodemographic factors 50 ADAS Cog 50 carotid stenosis 50 Symptom severity 50 eNO 50 gestational diabetes mellitus 50 TMS Therapy 50 proband 50 #q#.# deletion syndrome 50 Multiple linear regression 50 hepatic lesions 50 Home Buyer Seller 50 CIN2 + 50 MADRS score 50 Main Outcome Measure 50 adenotonsillectomy 50 abnormal cytology 50 multivariable Cox 50 polysomnography PSG 50 depressive symptoms 50 psychiatric comorbidity 50 ANOVA 50 nonadherence 50 neuropathologic 50 Heritability 50 Pharmacologic 50 prospectively defined 50 Treatment Outcome 50 secondary efficacy endpoint 50 dysthymic disorder 50 Sleep disordered breathing 50 attention-deficit/hyperactivity 50 Obsessive Compulsive Disorder OCD 50 Psychotic Disorders 50 ictal 50 haematologic 50 late onset hypogonadism 50 affective disorder 50 virological response 50 NIH CPSI 50 tipranavir ritonavir 50 allele frequencies 50 acute myocardial ischemia 50 neuroimaging studies 50 Liver biopsies 50 Randomized Controlled Trials 50 subtests 50 emotional dysregulation 50 somatic complaints 50 Subgroup analyzes 50 prodromal symptoms 50 MetS 50 Kraepelin 50 BEXXAR Therapeutic Regimen 50 concomitant medications 50 #F FDG PET 50 HIV tropism 50 HIV HCV coinfected 50 EPDS 50 univariate analysis 50 Depression Inventory 50 Bonferroni 49 neuroanatomical 49 Interpersonal psychotherapy 49 Response Evaluation Criteria 49 Logistic regression analysis 49 MSLT 49 pain catastrophizing 49 internalizing behaviors 49 genotypic resistance 49 microalbumin test 49 psychotherapeutic interventions 49 NYHA functional class 49 dysthymia 49 Risk Stratification 49 AUDs 49 State Examination MMSE 49 therapy CBT 49 etiologic 49 Reynolds Risk Score 49 externalizing disorders 49 MDRD equation 49 hypomania 49 preoperative evaluation 49 psychotic disorders 49 YMRS 49 Negative Symptoms 49 rheumatoid factor 49 sonographic diagnosis 49 polysomnographic 49 psychometric assessments 49 DRD2 49 Seattle Angina Questionnaire 49 Schizoaffective Disorder 49 prostate cancer CaP 49 Socio demographic 49 NAMCS 49 trials RCTs 49 thrombophilia 49 serologic 49 androgen depletion 49 overt nephropathy 49 neuropsychological 49 Change PGIC 49 Prehypertension 49 Hopkins Symptom Checklist 49 functional neuroimaging 49 serotonin reuptake inhibitors 49 Electroconvulsive therapy 49 guanfacine extended release 49 MDRD 49 cognitive behavioral therapies 49 cold pressor test 49 prognostic variables 49 cognitive behavioral 49 rFSH 49 fraternal twin pairs 49 thyrotropin levels 49 sd = 49 Subgroup analysis 49 episodic migraine 49 pyridostigmine 49 CPAP adherence 49 ADCS CGIC 49 hyperactivity inattention 49 nonepileptic seizures 49 Atypical antipsychotics 49 mm Hg diastolic 49 dosage regimens 49 PsA 49 orofacial pain 49 CANCIDAS 49 immunohistochemical 49 male Wistar rats 49 serum estradiol 49 mean ± SEM 49 T1DM 49 endometrial thickness 49 lipid abnormalities 49 RECIST Response Evaluation Criteria 49 bone scintigraphy 49 PsychTests 49 THIS STUDY 49 extraversion 49 Cognitive Behavioral Therapy CBT 49 Atomoxetine 49 acetabular fractures 49 anthropometric measurements 49 PERMP 49 BPS IC 49 biochemical recurrence 49 nondepressed 49 hyperkinetic disorder 49 NIHSS score 49 interobserver reliability 49 EarlyCDT Lung 49 Urogenital Distress Inventory 49 CT perfusion 49 Solid Tumours 49 Charlson Comorbidity Index 49 hyperarousal 49 D Cycloserine 49 differentially expressed genes 49 psychometrically 49 neuropsychological evaluations 49 HOMA IR 49 System IPSS 49 neurocognitive functioning 49 Maslach Burnout Inventory 49 hyperprolactinemia 49 Renal Function 49 ELBW infants 49 carotid intima media 49 metabolite concentrations 49 aldosterone antagonist 49 Randomized controlled 49 Cardiotoxicity 49 histological subtype 49 cognitive domains 49 Cognitive Behavior Therapy 49 aspartate aminotransferase AST 49 liver biopsies 48 Visual Analog Scale 48 cTnT 48 anthropometric 48 Clinician Administered PTSD 48 clinicopathologic 48 Echocardiographic 48 plain radiographs 48 Conscientiousness 48 non affective psychosis 48 Interpersonal Psychotherapy 48 Visual Analogue Scale VAS 48 aripiprazole 48 PSQI 48 Pathologic 48 Severe Primary IGFD 48 OSAHS 48 Montgomery Asberg Depression 48 Scale Cognitive Subscale 48 temper dysregulation disorder 48 interpersonal psychotherapy IPT 48 Y BOCS 48 idiopathic Parkinson disease 48 MMSE scores 48 Services #:#-#,# Abstract 48 angiographically 48 silent myocardial ischemia 48 behavioral disinhibition 48 osteopenic 48 dietary questionnaires 48 clinicopathological features 48 Bulimia Nervosa 48 DLQI 48 NHANES III 48 Outcome Measures 48 Regression analyzes 48 MoxDuo TM IR 48 efavirenz EFV 48 dose proportionality 48 Natural Catastrophe Stress 48 venlafaxine Effexor 48 psychometrically sound 48 Mood disorders 48 multivariate regression 48 antidepressant efficacy 48 subscore 48 Generalized Anxiety Disorder GAD 48 HADS 48 suicidal ideation 48 Functional neuroimaging 48 orthostatic 48 meta analytic 48 fluoxetine paroxetine 48 Narcissistic Personality Inventory 48 Heterogeneity 48 linear regressions 48 mammographically 48 chronic prostatitis 48 Mental Component 48 CALERIE 48 psychometric testing 48 Research Diagnostic Criteria 48 FACIT 48 Pain Rating Scale 48 fibromyalgia syndrome 48 Cronbach alpha 48 meta analytic review 48 endophenotypes 48 Wernicke Korsakoff syndrome 48 WOMAC pain 48 nonpsychiatric 48 bipolar affective disorder 48 medically unexplained 48 VaD 48 nonrandomized studies 48 prostate cancer PCa 48 immunochemical fecal occult 48 amnestic MCI 48 electroencephalographic 48 IQR 48 POAG 48 attention-deficit/hyperactivity disorder ADHD 48 Major depressive disorder 48 adenoidectomy 48 Decitabine 48 carotid IMT 48 liver histology 48 posttransplant 48 Main Outcome Measures 48 Test Methodology 48 Histological 48 Socioeconomic status 48 nocturnal enuresis 48 borderline personality disorder 48 Rh factor 48 MDCT angiography 48 oncologic outcomes 48 FDG PET imaging 48 postmenopausal osteoporotic women 48 neuro psychological 48 5 HTTLPR 48 underwent CABG 48 multivariable analysis 48 Anxiety disorders 48 Cognitive Abilities Test 48 Relapsing Remitting Multiple Sclerosis 48 APTIVUS r 48 RCTs 48 generalizability 48 allostatic load 48 psychometric tests 48 hypogonadal men 48 mania hypomania 48 urinary incontinence UI 48 chromium picolinate supplementation 48 SGRQ 48 CAARS 48 HDRS 48 reboxetine 48 muscle dysmorphia 48 confounder 48 Venous thromboembolism 48 Women Ischemia Syndrome 48 HeFH 48 neuropsychological assessments 48 tumor histology 48 salivary cortisol 48 nonoperative treatment 48 systolic hypertension 48 pharmacologic treatments 48 acute mania 48 thorough QT 48 Diagnostic Statistical Manual 48 diagnosing bipolar disorder 48 myocardial viability 48 psychotherapies 48 ER CHOP 48 SGAs 48 clinicopathological 48 preoperative diagnosis 48 Pharmacodynamic 48 Cronbach 48 â ‰ ¥ 48 MBq 48 colposcopic 48 ADAS cog 48 biopsychosocial 48 desvenlafaxine succinate 48 longitudinal cohort study 48 Transcranial magnetic stimulation 48 TT genotype 48 cardiac channelopathies 48 Psychometric testing 48 amisulpride 48 MBCT 48 covariance ANCOVA 48 calcaneal fractures 48 FDG PET scans 48 HER2 expression 48 BMI z 48 adjuvant systemic 48 Psoriasis Area 48 postoperative complication 48 prespecified criteria 48 CHADS2 48 postprocedure 48 psychosocial interventions 47 Univariate analysis 47 chlorpromazine 47 Anthropometric 47 eC SSRS 47 LUTS 47 Cognitive Behavioral Therapy 47 PCa 47 PCWP 47 dopamine receptor gene 47 Scale PANSS 47 Erectile Function IIEF 47 cerebral microbleeds 47 adjunctive ABILIFY 47 subthreshold depression 47 atherothrombotic disease 47 neuro cognitive 47 Sjögren syndrome 47 Comorbidities 47 neuropsychological testing 47 guideline concordant 47 HIV uninfected 47 functional gastrointestinal disorders 47 sonographic examinations 47 diabetes dyslipidemia 47 PON1 activity 47 echocardiographic 47 PLMs 47 psychiatric disorders 47 dyads 47 MBSR 47 tricyclic antidepressant 47 Alzheimer Disease Assessment 47 moderately heritable 47 SSRI citalopram 47 FEV ^ sub 47 elevated ALT 47 psychopathy 47 multivariable analyzes 47 manic depressive illness 47 body dysmorphic disorder 47 tapentadol IR 47 divalproex sodium 47 coinfected patients 47 neurophysiologic 47 comorbid ADHD 47 extrapyramidal symptoms 47 SSRI SNRI 47 androgen suppression 47 Cognitive behavioral therapy 47 microsatellite instability 47 androgen excess 47 Depression Scale 47 ragweed allergic 47 scintigraphic 47 neuropsychiatric disorder 47 autistic traits 47 prodromal 47 nonbacterial prostatitis 47 inflammatory biomarkers 47 Acute Physiology 47 underwent coronary angiography 47 tolerability pharmacokinetics 47 Major Depressive Disorder MDD 47 Clinical Psychiatry 47 symptomatic VTE 47 Kaplan Meier analysis 47 metabolic parameters 47 Binge eating 47 major depressive disorder 47 Minnesota Multiphasic Personality Inventory 47 colonoscopic 47 explanatory variables 47 schizotypal personality disorder 47 D dimer 47 empiric 47 aetiology 47 Erectile function 47 Health Assessment Questionnaire 47 BENICAR HCT 47 CAMMS# 47 GPRD 47 nonobese 47 airway hyperresponsiveness 47 disorder OCD 47 State Exam MMSE 47 oral glucose tolerance 47 regression analyzes 47 sleeve lobectomy 47 Clinical Antipsychotic Trials 47 Alcohol Dependence 47 ziprasidone Geodon 47 undergone radical prostatectomy 47 psychostimulants 47 nonfasting 47 neuroleptics 47 macroalbuminuria 47 Nesiritide 47 psychobiological 47 Scale cognitive subscale 47 INVEGA ® 47 Screening Trial 47 ß blockers 47 Motivational Interviewing 47 histopathologic 47 Radical prostatectomy 47 multivariable adjusted 47 Functional Capacity 47 psychopathological 47 risperidone Risperdal 47 Assessment Questionnaire 47 antiepileptic medications 47 PREZISTA ritonavir 47 motivational interviewing 47 Coronary CTA 47 PROMs 47 genomewide 47 digital rectal examination 47 Psychopathy 47 alteplase 47 ASPD 47 Mental Disorders IV 47 df = 47 β blockers 47 acute subacute 47 Lu AA# 47 CRQ 47 Fibromyalgia syndrome 47 immunohistochemical staining 47 intact parathyroid hormone 47 posttraumatic stress disorder PTSD 47 Adult ADHD 47 dissociative symptoms 47 cervical cytology 47 Postural 47 Secondary endpoints 47 Prognostic 47 longitudinal observational study 47 Screening Questionnaire 47 Score DAS 47 Duloxetine 47 correlation coefficients 47 METHODS 47 androgenetic alopecia 47 hamartomas 47 NSQIP 47 DEXA scans 47 Mantoux test 47 androgen deficiency 47 % CI #.#-#.# [003] 47 antidepressant therapy 47 oxygen desaturation 47 androgen deprivation 47 substance induced psychosis 47 treatment emergent AEs 47 transrectal ultrasound guided 47 RRMS patients 47 generalized epilepsy 47 RECIST criteria 47 adenomatous polyps 47 oral prednisolone 47 clomipramine 47 Functioning Scale 47 extramedullary 47 Score IPSS 47 APACHE II 47 Nord Trøndelag Health 47 premenstrual dysphoric disorder 47 Pharmacokinetic 47 Rating Scale MADRS 47 Glasgow Coma Scale 47 deCODE BreastCancer TM 47 subjective sleepiness 47 Wechsler Memory 47 perceptual reasoning 47 dose escalation phase 47 Cystic Fibrosis Questionnaire Revised 47 manic depression bipolar disorder 47 vasomotor 47 summative 47 schizoaffective disorders 47 psychotherapeutic treatment 47 neurobehavioural 47 Health Questionnaire PHQ 47 multivariable 46 pharmacokinetic parameters 46 NATRECOR ® 46 comorbidities 46 demyelinating 46 Functional Assessment 46 intraclass correlation coefficient 46 shorter telomere length 46 biochemical relapse 46 nonischemic 46 Personality traits 46 pharmacodynamic parameters 46 recurrent miscarriage 46 nodal metastases 46 mild renal insufficiency 46 Mini Mental 46 generalized linear 46 biopsychosocial model 46 baseline LDH 46 SF #v# 46 Genotypes 46 dyslipidaemia 46 secondary efficacy endpoints 46 neurodevelopmental outcome 46 atherogenic dyslipidemia 46 CTEPH 46 fasting plasma 46 EEG abnormalities 46 paricalcitol 46 IPAH 46 Efficacy endpoints 46 Intervention Trial 46 endoscopic examinations 46 antiretroviral naïve 46 congenital toxoplasmosis 46 conventional angiography 46 poststroke depression 46 Observational studies 46 inferential statistics 46 DEXA scan 46 psychosocial distress 46 echocardiographic parameters 46 observable characteristics 46 VFQ 46 neuropsychological impairments 46 Randomised 46 citalopram 46 Hamilton Rating Scale 46 lamotrigine 46 UKPDS 46 acetabular dysplasia 46 nonparametric 46 CARDIA 46 CONCERTA ® 46 NATRECOR R 46 weekly subcutaneous injections 46 Autism Spectrum Disorders ASDs 46 Kaplan Meier curve 46 methodologic 46 Dr. Gabriella Gobbi 46 diagnosable disorder 46 tic disorders 46 fluoxetine Prozac 46 posttraumatic stress disorder 46 neuropsychiatric symptoms 46 Overactive Bladder 46 specific antigen PSA 46 Not Otherwise Specified 46 Psychotropic medications 46 timepoints 46 2 diabetes T2D 46 coronary CTA 46 Pharmacotherapy 46 Natalizumab 46 migraine prophylaxis 46 serum lipid levels 46 Thrombolysis 46 ADCS ADL 46 BMI ≥ 46 stratifying patients 46 histologically proven 46 Hutchinson Gilford progeria 46 randomized multicenter trial 46 Antidepressant medications 46 methacholine challenge 46 International Prostate Symptom 46 Postoperative 46 urodynamic studies 46 Tasigna prolongs 46 opioid dependent 46 nonfatal MI 46 neuroleptic drugs 46 abdominal adiposity 46 Obstructive Sleep Apnea OSA 46 glioma tumors 46 endoscopists 46 AAT deficiency 46 prospective observational cohort 46 cTnT levels 46 oral anticoagulation 46 Affective Disorders 46 methotrexate monotherapy 46 RLS sufferers 46 symptomatic BPH 46 albumin excretion 46 Medication adherence 46 plasma lipid 46 zonisamide SR 46 Diabetes mellitus 46 hemodynamic parameters 46 Ejection Fraction 46 bipolar disorders 46 QOL questionnaire 46 premenopause 46 neuropsychological functioning 46 parkinsonian 46 callous unemotional traits 46 PANSS scores 46 HBeAg negative patients 46 sertraline Zoloft 46 Chronic pelvic 46 biostatistical analysis 46 Generalized anxiety disorder 46 hypoactive 46 Fibromyalgia Impact Questionnaire 46 anthropometric measures 46 Functional Outcomes 46 experimental allergic encephalomyelitis 46 developmental dyscalculia 46 SPECT MPI 46 Cognitive Impairment 46 urinary cortisol 46 intracranial hypertension 46 white matter hyperintensities 46 hypomanic episodes 46 psychosocial variables 46 blood Phe levels 46 GABRA2 46 nonpharmacological treatments 46 paroxetine Paxil 46 mammographic density 46 PREZISTA r 46 relapsed MM 46 EEG biofeedback 46 citalopram Celexa 46 pretest probability 46 narcolepsy cataplexy 46 Multivariate analyzes 46 menopausal symptom 46 Outcomes Study 46 nonadherent 46 D Sequenced Treatment 46 MR spectroscopy 46 meta cognitive 46 Panic Disorder 46 serum vitamin D 46 Logistic Regression 46 underwent radical prostatectomy 46 psychosocial stressors 46 Obsessive compulsive disorder OCD 46 generalized anxiety disorder GAD 46 attention-deficit/hyperactivity disorder 46 EuroSCORE 46 Chronic Fatigue Syndrome CFS 46 genomic alterations 46 noncardiac chest pain 46 juvenile idiopathic arthritis JIA 46 decrements 46 ImmuKnow assay 46 antiangiogenic therapy 46 Analytical Reasoning 46 polyarticular 46 nonpharmacological 46 % CI #.#-#.# [008] 46 vesicoureteral reflux 46 BRCA testing 46 schizoid personality disorder 46 unstable angina pectoris 46 antenatal depression 46 tic disorder 46 Multivariable logistic regression 46 manic depressive disorder 46 PITX2 methylation 46 left ventricular diastolic 46 chest radiographs 46 Decety 46 Attention-Deficit/Hyperactivity Disorder 46 Aripiprazole 46 ophthalmoscopy 46 voiding dysfunction 46 subclinical atherosclerosis 46 transcriptomic 46 coronary calcification 46 NLSY 46 assortative mating 46 summative assessments 46 Verbal Behavior 46 BODE index 46 proliferative diabetic retinopathy 46 Insulin sensitivity 46 demographic variables 46 acamprosate 46 Cognitive Behavioural Therapy 46 pressor response

Back to home page